Peddock Capital Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,896
Closed -$983K 249
2019
Q3
$983K Sell
9,896
-1,975
-17% -$188K 0.55% 42
2019
Q2
$1.1M Sell
11,871
-35
-0.3% -$3.32K 0.58% 42
2019
Q1
$1.12M Sell
11,906
-272
-2% -$23.8K 0.61% 35
2018
Q4
$780K Sell
12,178
-1,536
-11% -$113K 0.46% 47
2018
Q3
$1.23M Sell
13,714
-719
-5% -$63.5K 0.59% 34
2018
Q2
$1.15M Buy
14,433
+53
+0.4% +$4.4K 0.57% 34
2018
Q1
$1.28M Buy
14,380
+1,371
+11% +$132K 0.68% 28
2017
Q4
$1.36M Sell
13,009
-1,295
-9% -$146K 0.68% 29
2017
Q3
$2.09M Buy
14,304
+73
+0.5% +$9.94K 1.07% 12
2017
Q2
$1.85M Buy
14,231
+396
+3% +$48.5K 0.98% 12
2017
Q1
$1.72M Buy
13,835
+684
+5% +$81.9K 0.99% 13
2016
Q4
$1.52M Buy
13,151
+700
+6% +$78K 0.89% 15
2016
Q3
$1.3M Hold
12,451
0.8% 18
2016
Q2
$1.23M Buy
12,451
+61
+0.5% +$6.31K 0.78% 21
2016
Q1
$1.24M Buy
12,390
+313
+3% +$32.2K 0.94% 20
2015
Q4
$1.45M Buy
12,077
+378
+3% +$43.7K 1.11% 14
2015
Q3
$1.26M Buy
11,699
+189
+2% +$23.5K 1.15% 18
2015
Q2
$1.33M Buy
11,510
+324
+3% +$37K 1.09% 17
2015
Q1
$1.29M Hold
11,186
1.07% 15
2014
Q4
$1.25M Buy
11,186
+166
+2% +$17.5K 1.01% 16
2014
Q3
$1.04M Hold
11,020
0.85% 26
2014
Q2
$946K Buy
11,020
+248
+2% +$18.9K 0.71% 34
2014
Q1
$752K Buy
10,772
+842
+8% +$66.7K 0.59% 36
2013
Q4
$839K Buy
+9,930
New +$786K 0.65% 36

Other funds holding CELG

Peddock Capital Advisors's CELG Position: Q4 2019 in Review

Peddock Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,896 shares — an estimated $983K sold.

Peddock Capital Advisors first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $2.09M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Peddock Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Peddock Capital Advisors sold 9,896 Celgene Corp shares in Q4 2019, an estimated $983K.
  • Peddock Capital Advisors first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
  • Peddock Capital Advisors's Celgene Corp position peaked at $2.09M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Peddock Capital Advisors's 13F filing for Q4 2019, filed 24 Jan 2020.